Fresh from signing an alliance with Novartis, Chai Discovery has raised $400 million in a third-round financing to support ...

Spero Therapeutics has licensed rights to an anti-CD40L antibody developed by China's Innovent Biologics, planning to develop ...

New biotech Avere Therapeutics has taken a fast-track to becoming a publicly listed company by merging with NextCure, with a ...

Biogen and Ionis have revealed the first clinical results with tau-targeting Alzheimer's drug candidate diranersen, showing ...

The University of Oxford has launched what it says is the world's first phase I clinical trial of a vaccine specifically ...

An alarming study has found that people who suffer a serious heart attack are more likely to have micro and nanoplastics ...

What receives far less attention is what happens to the data that was stolen before the encryption even started, and where it ends up in the weeks and months that follow. TrendAI’s latest research ...

AstraZeneca has continued its pipeline-boosting deal spree in China with a $1.5 billion agreement that gives it global rights ...

After a delay, Eisai and Biogen have won FDA approval for their new subcutaneous formulation of Alzheimer's disease therapy ...

A study has shown that, for people living with advanced cancer, a simple, weekly remote check-in with their care team can ...

A federal judge in the US has sided with Amgen in a dispute over a price cap imposed by the state of Colorado on its blockbuster immunology drug Enbrel. In a move viewed as a test of states' ability ...

Apnimed has joined the IPO queue on the Nasdaq, hoping to raise additional funding for its late-stage oral therapy for ...